The above results showed that KDELR1 overexpression is positively associated with unfavorable clinical features, such as higher WHO grades, the mesenchymal subtype, recurrence, older age, and GBM, which indicates that KDELR1 might be an unfavorable prognostic factor in gliomas. This evidence concerns the gene KDELR1 and central nervous system cancer.